331031
Maternal Influenza Review Program: Identifying Barriers to Maternal Immunization
To facilitate development of strategies to reduce hospitalizations and increase influenza vaccination rates in pregnant women, ACOG conducted a four state pilot project modeled after the Fetal Infant Mortality Review (FIMR) Program focused on improving the system of care for pregnant women with influenza. The FIMR methodology is an evidence-based process that employs an in-depth look at potentially preventable events such as system failures, lack of resources, or lack of education that result in an adverse outcome, in this case pregnant women hospitalized with influenza during the 2012-13 flu season. These reviews were conducted by a coalition of health care stakeholders coordinated by the State Departments of Health in each of the four pilot locations. Each state identified several barriers to maternal influenza immunization and influenza infection treatment that may have resulted in hospitalization. Based on findings from the review of cases by the four states, ACOG has compiled recommended strategies to improve immunization rates of pregnant women. Additional work will be funded to implement many of the recommendations for system change from each state.
Learning Areas:
Conduct evaluation related to programs, research, and other areas of practicePlanning of health education strategies, interventions, and programs
Protection of the public in relation to communicable diseases including prevention or control
Public health or related education
Learning Objectives:
Identify potential educational gaps and system failures contributing to influenza infection and hospitalization in pregnant women.
Discuss interventions to reduce the number of pregnant women hospitalized with influenza annually.
Keyword(s): Immunizations, Maternal and Child Health
Organization/institution whose products or services will be discussed: This presentation discusses the use of influenza vaccines during pregnancy. While the use of influenza vaccines in pregnant women is considered off-label, the Centers for Disease Control and Prevention along with many other organizations recommend their u
Qualified on the content I am responsible for because: As a consultant for the past seven years to the American College of Obstetricians and Gynecologists serving as both a topic expert on immunizations as well as evaluator on several funded ACOG immunization grants I am well versed on factors related to maternal influenza transmission. These funded projects have shown important barriers to immunization that have then been written up and disseminated to ACOG's membership as well as been included in presentations at conferences.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.